Directory
>
Ann Ferentz
Ann Ferentz
Executive Director, Regulatory Affairs | Bioverativ, a Sanofi company
Arlington, Massachusetts, United States
Ann Ferentz
Summary
Ann Ferentz is an accomplished executive with extensive experience in regulatory affairs within the biotechnology and pharmaceutical industries. Currently serving as the Executive Director of Regulatory Affairs at Bioverativ, a Sanofi company, she has a proven track record in clinical development and drug approval processes. Ann's academic background includes a PhD in Chemistry from Harvard University and a Bachelor's degree from Yale University, equipping her with a strong scientific foundation. With over two decades of experience, she has held various leadership roles at prominent organizations such as Biogen and Genzyme. Ann is passionate about advancing innovative therapies in oncology and has a keen interest in navigating complex regulatory landscapes. Her leadership style is characterized by a commitment to fostering collaboration and driving strategic initiatives. She is also known for her ability to mentor emerging talent in the field. Ann's contributions have significantly impacted the success of numerous clinical trials and regulatory submissions.
Ann Ferentz
Work Experience
Executive Director, Regulatory Affairs at
Bioverativ, a Sanofi company
February 2017 - Present
Associate Director, Regulatory Affairs at
Biogen
November 2015 - February 2017
Senior Manager, Regulatory Affairs at
Biogen
September 2012 - November 2015
Associate Director, Scientific Reporting at
SANOFI-AVENTIS AUSTRALIA PTY LTD
January 2010 - September 2012
Clinical Writing Lead at
Pfizer, Inc.
January 2003 - January 2010
Manager, Scientific Communications at
Variagenics
January 2001 - January 2003
Fellow at
Bunting Institute At Radcliffe College
January 1997 - January 1999
Ann Ferentz
Education
Harvard University, Phd
Yale University, Bs
Frequently Asked Questions about Ann Ferentz
What company does Ann Ferentz work for?
Ann Ferentz is a Executive Director, Regulatory Affairs at Bioverativ, a Sanofi company, a company specializing in Pharmaceutical preparations.
Where Ann Ferentz graduated from?
Ann Ferentz holds a degree in Chemistry from Harvard University.
Who is Ann Ferentz?
Ann Ferentz is an accomplished executive with extensive experience in regulatory affairs within the biotechnology and pharmaceutical industries. Currently serving as the Executive Director of Regulatory Affairs at Bioverativ, a Sanofi company, she has a proven track record in clinical development and drug approval processes. Ann's academic background includes a PhD in Chemistry from Harvard University and a Bachelor's degree from Yale University, equipping her with a strong scientific foundation. With over two decades of experience, she has held various leadership roles at prominent organizations such as Biogen and Genzyme. Ann is passionate about advancing innovative therapies in oncology and has a keen interest in navigating complex regulatory landscapes. Her leadership style is characterized by a commitment to fostering collaboration and driving strategic initiatives. She is also known for her ability to mentor emerging talent in the field. Ann's contributions have significantly impacted the success of numerous clinical trials and regulatory submissions.
Ann`s contact details
Colleagues
Executive Director, Regulatory CMC
Executive Director, Market Access, Head of Us Commercial Contract and Trade Operations